Racial differences in operating characteristics of prostate cancer screening tests

Journal of Urology

Volumn 158, Issue 5, 1997, Pages 1861-1866

  Smith, Deborah S ^a   Bullock, Arnold D ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CAUCASIAN; DIGITAL RECTAL EXAMINATION; HUMAN; MALE; NEGRO; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0030820023     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64147-8     Document Type: Article

References (24)

1. Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L. and Edwards, B. K.: Cancer Statistics Review, 1989. National Institutes of Health Publication No. 92-2789. Bethesda, Maryland: National Cancer Institute, 1992.
2. Wingo, P. A., Bolden, S., Tong, T., Parker, S. L., Martin L. M. and Heath, C. W., Jr.: Cancer statistics for African-Americans, 1996. CA, 46: 113, 1996.
3. Polednak, A. P. and Flannery, J. T.: Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer, 70: 2152, 1992.
4. Steele, G. D., Jr., Osteen, R.T., Winchester, D. P., Murphy, G. P. and Menck, H. R.: Clinical highlights from the National Cancer Data Base: 1994. CA, 44: 71, 1994.
5. Price, J. H., Colvin, T. L. and Smith, D.: Prostate cancer: perceptions of African-American males. J. Natl. Med. Ass., 85: 941, 1993.
6. Roach, M., III, Krall, J., Keller, J. W., Perez, C. A., Sause, W. T., Doggett, R. L., Rotman, M., Russ, H., Pilepich, M.V., Asbell, S.O. and Shipley, W.: The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int. J. Rad. Oncol. Biol. Phys., 24: 441, 1992.
7. Taylor, J. D., Holmes, T. M. and Swanson, G. M.: Descriptive epidemiology of prostate cancer in metropolitan Detroit. Cancer, 73: 1704, 1994.
8. Austin, J. P., Aziz, H., Potters, L., Thelmo, W., Chen, P., Choi, K., Brandys, M., Macchia, R. J. and Rotman, M.: Diminished survival of young blacks with adenocarcinoma of the prostate. Amer. J. Clin. Oncol., 13: 465, 1990.
9. Mettlin, C., Murphy, G. P. and Menck, H.: Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990. Urology, 43: 488, 1994.
10. Gornick, M. E., Eggers, P. W., Reilly, T. W., Mentnech, R. M., Fitterman, L. K., Kucken, L. E. and Vladeck, B. C.: Effects of race and income on mortality and use of services among medicare beneficiaries. New Engl. J. Med., 335: 791, 1996.
11. Ross, R. K., Bernstein, L., Lobo, R. A., Shimizu, H., Stanczyk, F. Z., Pike, M. C. and Henderson, B. E.: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet, 339: 887, 1992.
12. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. J.A.M.A., 274: 1599, 1995.
13. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
14. Demark-Wahnefried, W., Strigo, T., Catoe, K., Conaway, M., Brunetti, M., Rimer, B. K. and Robertson, C. N.: Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology, 46: 346, 1995.
15. Smith, D. S., Bullock, A. D., Catalona, W. J. and Herschman, J. D.: Racial differences in a prostate cancer screening study. J. Urol., 156: 1366, 1996.
16. Schatzkin, A., Connor, R. J., Taylor, P. R. and Bunnag, B.: Comparing new and old screening tests when a reference procedure cannot be preformed on all screenees. Example of automated cytometry for early detection of cervical cancer. Amer. J. Epidemiol., 125: 672, 1987.
17. Fleiss, J. L.: Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley and Sons, pp. 112-119, 1981.
18. Moul, J. W., Sesterhenn, I. A., Connelly, R. R., Douglas, T., Srivastava, S., Mostofi, F. K. and McLeod, D. G.: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. J.A.M.A., 274: 1277, 1995.
19. Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McCleod, D. G. and Moul, J. W.: Age-specific reference ranges for serum prostate-specific antigen in black men. New Engl. J. Med., 335: 304, 1996.
20. Stenman, U. H., Hakama, M., Knekt, P., Aromaa, A., Teppo, L. and Leinonen, J.: Serum concentrations of prostate specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet, 344: 1594, 1994.
21. Catalona, W. J., Smith, D. S. and Ornstein, D. K.: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: Enhancement of specificity with free PSA measurements. J.A.M.A., 277: 1452, 1997.
22. Mettlin, C., Jones, G., Averette, H., Gusberg, S. B. and Murphy, G. P.: Defining and updating the American Cancer Society Guidelines for the cancer-related checkup: prostate and endometrial cancers. CA, 43: 42, 1993.
23. Early detection of prostate cancer and use of transrectal ultrasound. In: American Urological Association 1992 Policy Statement Book. Baltimore: American Urological Association, chapt. 4, p. 20, 1992.
24. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostatic biopsies in men with persistently elevated serum PSA values. J. Urol., 151: 1571, 1994.